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Diﬀuse choroidal hemangiomas associated with Sturge-Weber syndrome (SWS) are classically treated with external beam
radiotherapy (EBR), but there are a few reports usually of single cases indicating the usefulness of plaque therapy. We present
our observations on two cases of diﬀuse choroidal hemangiomas with exudative retinal detachment associated with SWS treated
with Ruthenium-106 plaque therapy. Outcomes included best-corrected visual acuity (BCVA) and regression in tumor thickness
measured by ultrasonography. The initial BCVA of the aﬀected eyes was counting ﬁngers at 1 meter and light projection.
Pretreatment tumors thickness was 3.5mm and 4.7mm. In a follow-up period of 18–24 months, signiﬁcant reduction in thickness
of choroidal hemangiomas up to 1.2mm and 1.4mm with prompt resolution of exudative retinal detachment was observed.
BCVA achieved 20/200 and 20/400, respectively. The ﬁndings in this paper indicate that Ruthenium-106 plaque therapy is eﬀective
in treatment of diﬀuse choroidal hemangiomas associated with SWS.
1.Introduction
The Sturge-Weber syndrome (SWS), also called encepha-
lotrigeminalangiomatosis,isasporadicallyoccurringneuro-
cutaneousdisorderwithcapillaryvenousangiomasinvolving
the skin of the face, typically in the ophthalmic (V1) and
maxillary(V2)distributionsofthetrigeminalnerve,choroid,
and leptomeninges [1]. Choroidal hemangiomas are esti-
mated to occur in approximately one third of SWS cases, and
they may occur in childhood or in early adulthood [2].
Choroidal hemangiomas are usually diﬀuse, primarily re-
lated to the posterior pole, and often seen as orange-red,
ﬂat to moderately elevated masses. Diﬀu s ec h o r o i d a lh e m a n -
giomas may be associated with an exudative retinal detach-
ment with macular involvement, photoreceptor cell loss and
cystoid degeneration of the sensory retina causing visual loss
[3]. These benign tumors are classically treated with external
beam radiotherapy (EBR) [4, 5]. There are also reports on
singlecasesindicatingtheusefulnessofplaquetherapy[6,7].
We present our observations on two cases of diﬀuse
choroidal hemangiomas with exudative retinal detachment
associated with SWS treated with Ruthenium-106 plaque
therapy.
2. Report of Cases
2.1. Case 1. A 6-year-old girl presented with blurred vision
in the left eye of 1-month duration. On examination the best
corrected visual acuity (BCVA) was 20/20 OS and counting
ﬁngers at 1 meter OD. She had diﬀuse nevus ﬂammeus
involving the left upper eyelid, forehead, and bulbar con-
junctiva suggestive of Sturge-Weber syndrome (Figure 1).
No other pathology was found on slit-lamp examination.
The intraocular pressure was within normal limits. The
fundus of the left eye showed a diﬀuse red-orange choroidal
lesion involving the posterior pole and temporal part of the
fundus with exudative retinal detachment (Figure 2(a)). B-
scan ultrasonography demonstrated a diﬀuse choroidal mass
3.5mm in thickness and 15.8mm in diameter with regular
high internal reﬂectivity typical for choroidal hemangioma
(Figure 2(b)). The anterior segment and fundus of the right2 Case Reports in Ophthalmological Medicine
Figure 1: Diﬀuse nevus ﬂammeus involving the left upper eyelid
and forehead associated with Sturge-Weber syndrome.
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Quantel medical cinescan SV.4.07 Klinika Okulistyki UJCM Krakow
(b)
Figure 2: Fundus and B-scan ultrasonography demonstrating
diﬀuse choroidal hemangioma with extensive exudative retinal
detachment.
eye were normal. Computed tomography (CT) scans of
the brain were unremarkable. Nuclear magnetic resonance
(NMR) images showed the presence of a pineal gland cyst.
A Ruthenium-106 plaque (CCB, Bebig Isotopen, Germany)
was used which delivered a dose of 30Gy to the tumor apex.
(a)
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Figure 3: The same eye 18 months after Ruthenium-106 plaque
therapy—regression of the tumor, no subretinal ﬂuid is present.
At 1-month posttreatment, the thickness of the heman-
gioma had decreased to 2.1mm with partial resorption of
subretinal ﬂuid and BCVA was 20/400. Three months after
therapy, tumor thickness was 1.4mm, no retinal detachment
was observed and BCVA improved to 20/200. Six months
after treatment, BCVA was stable and the hemangioma was
nearly ﬂat (1.2mm) (Figures 3(a) and 3(b)). Next follow-up
visits performed at the 12th and 18th months after plaque
therapy revealed further stabilization of both functional and
anatomical outcomes. No radiation-induced complications
were observed.
2.2. Case 2. A 6-year-old girl presented with diﬀuse bilateral
nevus ﬂammeus involving the upper eyelids, forehead, and
elevated intraocular pressure in both eyes. Anamnesis re-
vealed episodes with epilepsy, which had started at the age
of 5 months. On examination, BCVA was 20/20 OD and
light projection OS. Anterior segment examination showed
the presence of conjunctival hemangioma in the left eye. The
intraocular pressure was 18mmHg OD and 17mmHg OS.
Fundoscopy of the left eye showed total exudative retinal
detachment. The fundus of the right eye was normal. A-
and B-scans ultrasonography of the left eye revealed diﬀuse
thickening of the choroid suggestive of diﬀuse choroidal
hemangioma and extensive exudative retinal detachment.
The tumor thickness was 4.7mm, with the largest diameterCase Reports in Ophthalmological Medicine 3
of 15.6mm. CT scans and NMR images of the brain showed
the presence of diﬀuse left cerebral angiomas. A Ruthenium-
106 plaque (CCB, Bebig Isotopen, Germany) was used and
delivered a dose of 30Gy to the tumor apex.
At 1-month posttreatment, the maximum thickness of
the choroidal hemangioma had decreased to 2.8mm with
partial subretinal ﬂuid resorption, BCVA was counting ﬁn-
g e r sat1met e rOS.Thef ollo wupspe rf o rmed3and6mo nths
after therapy showed decreased tumor thickness to 2.4 and
2.0mm, respectively. Six months after treatment, no serous
retinal detachment was present and BCVA was counting
ﬁngersat3mOS.After12months,thetumorthicknessmea-
sured 1.4mm and BCVA improved to 20/400. Twenty-four
months after treatment, tumor thickness was unchanged
and visual acuity remained stable. No radiation-induced
complications were noted.
3. Discussion
EBR has been recommended for diﬀuse choroidal heman-
giomas with the presence of exudative retinal detachment [4,
5]. However, this therapy is associated with slow absorption
of subretinal ﬂuid, usually taking months. Recurrence or
persistence of the exudative retinal detachment is often
observed, which makes additional EBR necessary with the
risk of cataract, radiation retinopathy, and neuropathy de-
velopment [5].
Brachytherapy with radon seeds for the treatment of
circumscribed choroidal hemangioma was ﬁrst described
by MacLean and Maumenee in 1960 [8]. Plaque radiation
therapy with Cobalt-60, Palladium-103, Iodine-125, and
Ruthenium-106 is considered an eﬀective and safe method
of therapy for large circumscribed choroidal hemangiomas
with subretinal ﬂuid [6, 7, 9, 10]. The literature describes
only three cases of diﬀuse choroidal hemangiomas treated
with plaque radiation therapy. Zografos et al. [6] used
Cobalt-60 applicators in two patients and Murthy et al.
[7] used a Ruthenium-106 plaque in one case of diﬀuse
choroidal hemangioma with exudative retinal detachment
associated with SWS. They observed early and complete
resolution of the subretinal ﬂuid and tumor regression with
i m p r o v e m e n ti nB C V Ai nt r e a t e de y e s .I no u rp a t i e n t s ,t h e
subretinal ﬂuid was completely resolved within 3–6 months
and the choroidal hemangiomas showed signiﬁcant size
reduction as observed on B-scan ultrasonography. Both pa-
tients demonstrated improvement in BCVA.
Our observations indicate that plaque therapy is an
eﬀective and safe treatment option for diﬀuse choroidal
hemangiomas associated with SWS.
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